Spine Align, a device company developing a portfolio of products that enable spine surgeons to measure, visualize and adjust patients' spinal alignment during surgery, closed a $1.75 million series seed round. Funds will support development and FDA 510(k) clearance for their LiveAlign™ platform in 2021.
LiveAlign leverages image-guided and robotic technologies to augment surgery with digital feedback. It enables on-demand, 3D, full-length measurements of a patient’s spine with a 95% reduction in time and an 80% reduction in radiation exposure compared to current x-ray technologies.
Spine Align was founded in 2017 in Baltimore, Maryland.